Nilai Aset Bersih altimmune.com (ALT)

This chart shows the market price of Altimmune, Inc. (ALT), currently held at 0.47, supported by growing confidence in its peptide platform for weight loss. Price stability is driven by an autonomous drug development cycle, which renders the asset a defensive asset regardless of the global economy. Altimmune, Inc. (ALT) serves as a leading biopharmaceutical creator of breakthrough metabolism correction agents, possessing colossal scientific potential.

ALT Kapitalisasi Buku Altimmune Corp (04.07.2022 - 27.10.2026)

Rincian metrik keuangan lan pasar Altimmune (ALT)

- rega lan prakiraan konsensus rega:

Rega Altimmune Pharma|ALT - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Altimmune Inc|ALT - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi Saham Altimmune|ALT - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku altimmune.com|ALT - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Altimmune, Inc.|ALT - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Altimmune Inc|ALT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Altimmune Inc

Pambiji fundamental perusahaan:Altimmune, Inc.

Book value represents the difference between all of a company's assets and liabilities. Growth in this figure confirms a strengthening financial foundation and the protection of investor capital. By analyzing the book equity chart, one can assess the real value of the business. For Altimmune, Inc. (ALT), this metric is supported by the development of Pemvidutide. The drug's high patent potential creates a significant technological barrier, increasing the intrinsic value of the assets.

Pesaing Altimmune, Inc.